These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
284 related articles for article (PubMed ID: 18844453)
1. Quantitative expression analysis and prognostic significance of the novel apoptosis-related gene BCL2L12 in colon cancer. Kontos CK; Papadopoulos IN; Scorilas A Biol Chem; 2008 Dec; 389(12):1467-75. PubMed ID: 18844453 [TBL] [Abstract][Full Text] [Related]
2. Prognostic value of the apoptosis related genes BCL2 and BCL2L12 in breast cancer. Thomadaki H; Talieri M; Scorilas A Cancer Lett; 2007 Mar; 247(1):48-55. PubMed ID: 16647810 [TBL] [Abstract][Full Text] [Related]
3. Expression analysis of BCL2L12, a new member of apoptosis-related genes, in colon cancer. Mathioudaki K; Scorilas A; Papadokostopoulou A; Xynopoulos D; Arnogianaki N; Agnanti N; Talieri M Biol Chem; 2004 Sep; 385(9):779-83. PubMed ID: 15493871 [TBL] [Abstract][Full Text] [Related]
4. Molecular analysis and prognostic impact of the novel apoptotic gene BCL2L12 in gastric cancer. Florou D; Papadopoulos IN; Scorilas A Biochem Biophys Res Commun; 2010 Jan; 391(1):214-8. PubMed ID: 19903463 [TBL] [Abstract][Full Text] [Related]
5. Quantitative expression analysis of the apoptosis-related gene, BCL2L12, in head and neck squamous cell carcinoma. Geomela PA; Kontos CK; Yiotakis I; Scorilas A J Oral Pathol Med; 2013 Feb; 42(2):154-61. PubMed ID: 22747515 [TBL] [Abstract][Full Text] [Related]
6. Expression analysis and study of KLK4 in benign and malignant breast tumours. Papachristopoulou G; Avgeris M; Scorilas A Thromb Haemost; 2009 Feb; 101(2):381-7. PubMed ID: 19190825 [TBL] [Abstract][Full Text] [Related]
7. Topotecan and methotrexate alter expression of the apoptosis-related genes BCL2, FAS and BCL2L12 in leukemic HL-60 cells. Floros KV; Talieri M; Scorilas A Biol Chem; 2006 Dec; 387(12):1629-33. PubMed ID: 17132110 [TBL] [Abstract][Full Text] [Related]
8. BCL2L12: a promising molecular prognostic biomarker in breast cancer. Tzovaras A; Kladi-Skandali A; Michaelidou K; Zografos GC; Missitzis I; Ardavanis A; Scorilas A Clin Biochem; 2014 Dec; 47(18):257-62. PubMed ID: 25230343 [TBL] [Abstract][Full Text] [Related]
9. Expression of transferrin receptor and ferritin H-chain mRNA are associated with clinical and histopathological prognostic indicators in breast cancer. Yang DC; Wang F; Elliott RL; Head JF Anticancer Res; 2001; 21(1B):541-9. PubMed ID: 11299801 [TBL] [Abstract][Full Text] [Related]
10. Alterations in mRNA expression of apoptosis-related genes BCL2, BAX, FAS, caspase-3, and the novel member BCL2L12 after treatment of human leukemic cell line HL60 with the antineoplastic agent etoposide. Floros KV; Thomadaki H; Florou D; Talieri M; Scorilas A Ann N Y Acad Sci; 2006 Dec; 1090():89-97. PubMed ID: 17384250 [TBL] [Abstract][Full Text] [Related]
11. Molecular response of HL-60 cells to mitotic inhibitors vincristine and taxol visualized with apoptosis-related gene expressions, including the new member BCL2L12. Thomadaki H; Floros KV; Scorilas A Ann N Y Acad Sci; 2009 Aug; 1171():276-83. PubMed ID: 19723066 [TBL] [Abstract][Full Text] [Related]
12. Breast cancer cells response to the antineoplastic agents cisplatin, carboplatin, and doxorubicin at the mRNA expression levels of distinct apoptosis-related genes, including the new member, BCL2L12. Thomadaki H; Scorilas A Ann N Y Acad Sci; 2007 Jan; 1095():35-44. PubMed ID: 17404015 [TBL] [Abstract][Full Text] [Related]
13. Overexpression of the novel member of the BCL2 gene family, BCL2L12, is associated with the disease outcome in patients with acute myeloid leukemia. Thomadaki H; Floros KV; Pavlovic S; Tosic N; Gourgiotis D; Colovic M; Scorilas A Clin Biochem; 2012 Nov; 45(16-17):1362-7. PubMed ID: 22728012 [TBL] [Abstract][Full Text] [Related]
14. Expression of BCL2L12, a new member of apoptosis-related genes, in breast tumors. Talieri M; Diamandis EP; Katsaros N; Gourgiotis D; Scorilas A Thromb Haemost; 2003 Jun; 89(6):1081-8. PubMed ID: 12783122 [TBL] [Abstract][Full Text] [Related]
15. BCL2L12 is a novel biomarker for the prediction of short-term relapse in nasopharyngeal carcinoma. Fendri A; Kontos CK; Khabir A; Mokdad-Gargouri R; Scorilas A Mol Med; 2011; 17(3-4):163-71. PubMed ID: 21152697 [TBL] [Abstract][Full Text] [Related]
16. Treatment of MCF-7 cells with taxol and etoposide induces distinct alterations in the expression of apoptosis-related genes BCL2, BCL2L12, BAX, CASPASE-9 and FAS. Thomadaki H; Talieri M; Scorilas A Biol Chem; 2006 Aug; 387(8):1081-6. PubMed ID: 16895478 [TBL] [Abstract][Full Text] [Related]
17. Thymidylate synthase expression correlates closely with E2F1 expression in colon cancer. Kasahara M; Takahashi Y; Nagata T; Asai S; Eguchi T; Ishii Y; Fujii M; Ishikawa K Clin Cancer Res; 2000 Jul; 6(7):2707-11. PubMed ID: 10914714 [TBL] [Abstract][Full Text] [Related]
18. Increased BCL2L12 expression predicts the short-term relapse of patients with TaT1 bladder cancer following transurethral resection of bladder tumors. Foutadakis S; Avgeris M; Tokas T; Stravodimos K; Scorilas A Urol Oncol; 2014 Jan; 32(1):39.e29-36. PubMed ID: 23790536 [TBL] [Abstract][Full Text] [Related]
19. Prognostic value of humbug gene overexpression in stage II colon cancer. Wang J; de la Monte SM; Sabo E; Kethu S; Tavares R; Branda M; Simao L; Wands JR; Resnick MB Hum Pathol; 2007 Jan; 38(1):17-25. PubMed ID: 17020779 [TBL] [Abstract][Full Text] [Related]
20. Apoptosis regulating genes, bcl-2 and bax, and human telomerase reverse transcriptase messenger RNA expression in adrenal tumors: possible diagnostic and prognostic importance. Kanauchi H; Wada N; Clark OH; Duh QY Surgery; 2002 Dec; 132(6):1021-6; discussion 1026-7. PubMed ID: 12490850 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]